![Alain Huriez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alain Huriez
Fondateur chez
Luxfold S.A.
Profil
Alain Huriez is the founder of Luxfold S.A. (2013), Tc Land Expression SA (2002), AdBio Partners SAS (2015), and Samabriva SA (2011).
Titles held include Managing Partner at AdBio Partners SAS and Director at Samabriva SA. Current jobs include Director at Tridek-One Therapeutics SAS, Alderaan Biotechnology SAS, Augustine Therapeutics NV, and DiogenX SAS, and Venture Partner at Advent Venture Partners LLP since 2022.
Former jobs include Chairman & Chief Executive Officer at Neovacs SA, Chairman at Urania Therapeutics SAS, and Chairman at Orphalan SA from 2015 to 2022.
Education includes a graduate degree from Université Paris 1 Panthéon-Sorbonne (1996) and an MBA (1988) and doctorate (1989) from Université De Picardie Jules Verne.
Postes actifs de Alain Huriez
| Sociétés | Poste | Début |
|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Private Equity Investor | 01/06/2012 |
Luxfold S.A.
 Luxfold S.A. BiotechnologyHealth Technology Designs and engineers protein structures | Fondateur | 11/07/2013 |
AdBio Partners SAS
 AdBio Partners SAS Investment ManagersFinance AdBio Partners invests in companies located in Europe. The firm focuses on the life sciences sector. It participates in early stage capital transactions. | Fondateur | 25/11/2015 |
Alderaan Biotechnology SAS
 Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer | Directeur/Membre du Conseil | - |
Augustine Therapeutics NV
 Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Provides therapies for tooth and neuromuscular diseases | Directeur/Membre du Conseil | - |
DiogenX SAS
 DiogenX SAS BiotechnologyHealth Technology Operates as preclinical stage biotech company, that engages in develops and research biologics therapeutics options for diabetic patients | Directeur/Membre du Conseil | - |
Tridek-One Therapeutics SAS
 Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in other physical and natural sciences | Directeur/Membre du Conseil | - |
Samabriva SA
 Samabriva SA Miscellaneous Commercial ServicesCommercial Services Provides biological technical services | Fondateur | 01/01/2011 |
Anciens postes connus de Alain Huriez
| Sociétés | Poste | Fin |
|---|---|---|
Orphalan SA
 Orphalan SA Pharmaceuticals: MajorHealth Technology Develops and commercializes orphan drugs | Président | - |
| ░░ ░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░ | - |
Formation de Alain Huriez
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Neovacs SA
 Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Develops gene expression biomarkers for transplantation and auto-immune disorders | Commercial Services |
Université De Picardie Jules Verne
 Université De Picardie Jules Verne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Luxfold S.A.
Luxfold S.A. BiotechnologyHealth Technology Designs and engineers protein structures | Health Technology |
Samabriva SA
Samabriva SA Miscellaneous Commercial ServicesCommercial Services Provides biological technical services | Commercial Services |
Orphalan SA
Orphalan SA Pharmaceuticals: MajorHealth Technology Develops and commercializes orphan drugs | Health Technology |
AdBio Partners SAS
AdBio Partners SAS Investment ManagersFinance AdBio Partners invests in companies located in Europe. The firm focuses on the life sciences sector. It participates in early stage capital transactions. | Finance |
Tridek-One Therapeutics SAS
Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in other physical and natural sciences | Commercial Services |
Urania Therapeutics SAS
 Urania Therapeutics SAS BiotechnologyHealth Technology Operates biopharmaceutical company that develops read-through compounds | Health Technology |
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer | Health Technology |
Augustine Therapeutics NV
Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Provides therapies for tooth and neuromuscular diseases | Health Services |
DiogenX SAS
DiogenX SAS BiotechnologyHealth Technology Operates as preclinical stage biotech company, that engages in develops and research biologics therapeutics options for diabetic patients | Health Technology |
